17 News & Informationen zur MiMedx Aktie

  • Stocks That Hit 52-Week Highs On Friday
    benzinga.com

    Stocks That Hit 52-Week Highs On Friday

    Before 10 a.m. ET Friday, 183 stocks hit new 52-week highs.
    Areas of Significance: Alphabet (NASDAQ:GOOG) was the biggest firm by market cap …

  • MIMEDX Announces Filing Of Shelf Registration Statement With Securities And Exchange Commission
    thestreet.com

    MIMEDX Announces Filing Of Shelf Registration Statement With Securities And Exchange Commission

    S-3 Eligibility Enabled by Accomplishment of Multiple Financial Milestones
    MARIETTA, Ga., Aug. 27, 2021 (GLOBE NEWSWIRE) — MiMedx Group, Inc. (Nasdaq: MDXG)

  • The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology...
    markets.businessinsider.com

    The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration

    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Au…

  • MiMedx To Report Key Data This Summer
    markets.businessinsider.com

    MiMedx To Report Key Data This Summer

    (RTTNews) – Shares of MiMedx Group Inc. (MDXG) have more than doubled from their 52-week low of $5.32, recorded last November, to trade around $13…

  • Thompson Investment Management, Inc. Buys Viatris Inc, Discovery Inc, Kimberly-Clark Corp, Sells General Electric Co, Darden Restaurants...
    gurufocus.com

    Thompson Investment Management, Inc. Buys Viatris Inc, Discovery Inc, Kimberly-Clark Corp, Sells General Electric Co, Darden Restaurants Inc, Sysco Corp

    GuruFocus Article or News written by insider and the topic is about:

  • MIMEDX Promotes Marion Snyder to Chief of Staff, Senior Vice President, Government Affairs
    globenewswire.com

    MIMEDX Promotes Marion Snyder to Chief of Staff, Senior Vice President, Government Affairs

    Promotion Recognizes Skilled Leadership and Contributions to MIMEDX’s Continued Growth MARIETTA, Ga., Aug. 12, 2021 (GLOBE NEWSWIRE) — MiMedx Group,…

  • Regenerative Medicine Market Size Worth $57.08 Billion By 2027: Grand View Research, Inc.
    markets.businessinsider.com

    Regenerative Medicine Market Size Worth $57.08 Billion By 2027: Grand View Research, Inc.

    SAN FRANCISCO, Aug. 12, 2021 /PRNewswire/ — The global regenerative medicine market size is expected to reach USD 57.08 billion by 2027, growing …

  • MDXG: 2Q:21 Update
    markets.businessinsider.com

    MDXG: 2Q:21 Update

    By John Vandermosten, CFA NASDAQ:MDXG READ THE FULL MDXG RESEARCH REPORT Second Quarter 2021 Financial and Operational Results On August 3,…

  • MIMEDX Announces Second Quarter 2021 Operating and Financial Results
    globenewswire.com

    MIMEDX Announces Second Quarter 2021 Operating and Financial Results

    Second Quarter Net Sales Increase 27% to $68.2 million Versus Q2 2020 On Track to Deliver Topline Results for Late-Stage Musculoskeletal Pipeline in Late…

  • Cordant, Inc. Buys iShares Core MSCI International Developed Markets , Nano X Imaging, FireEye Inc, Sells Ubiquiti Inc, Vericel Corp,...
    gurufocus.com

    Cordant, Inc. Buys iShares Core MSCI International Developed Markets , Nano X Imaging, FireEye Inc, Sells Ubiquiti Inc, Vericel Corp, MiMedx Group Inc

    GuruFocus Article or News written by insider and the topic is about:

  • Were Hedge Funds Right About Piling Into Green Brick Partners Inc (GRBK)?
    insidermonkey.com

    Were Hedge Funds Right About Piling Into Green Brick Partners Inc (GRBK)?

    In this article you are going to find out whether hedge funds think Green Brick Partners Inc (NASDAQ:GRBK) is a good investment right now. We like to…

  • MIMEDX To Host Second Quarter 2021 Operating And Financial Results Conference Call On August 4
    thestreet.com

    MIMEDX To Host Second Quarter 2021 Operating And Financial Results Conference Call On August 4

    MARIETTA, Ga., July 20, 2021 (GLOBE NEWSWIRE) — MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), an industry leader in utilizing amniotic tissue

  • Regenerative Medicine Market Research Report 2021-2030: Emerging Economies are Key Opportunity Areas for Market Players
    prnewswire.com

    Regenerative Medicine Market Research Report 2021-2030: Emerging Economies are Key Opportunity Areas for Market Players

    /PRNewswire/ — The “Regenerative Medicine Market Research Report: By Type (Cell Therapy, Gene Therapy, Tissue Engineered Products), Application…

  • Regenerative Medicine Market Research Report 2021-2030: Emerging Economies are Key Opportunity Areas for Market Players
    markets.businessinsider.com

    Regenerative Medicine Market Research Report 2021-2030: Emerging Economies are Key Opportunity Areas for Market Players

    DUBLIN, July 16, 2021 /PRNewswire/ — The 'Regenerative Medicine Market Research Report: By Type (Cell Therapy, Gene Therapy, Tissue Engineered Pr…

  • The Worldwide Soft Tissue Allografts Industry Is Expected To Reach $6.6 Billion By 2026
    thestreet.com

    The Worldwide Soft Tissue Allografts Industry Is Expected To Reach $6.6 Billion By 2026

    DUBLIN, July 15, 2021 /PRNewswire/ — The

  • Activist investor discloses stake in MiMedx and suggests company to consider strategic alternatives (NASDAQ:MDXG)
    seekingalpha.com

    Activist investor discloses stake in MiMedx and suggests company to consider strategic alternatives (NASDAQ:MDXG)

  • The Daily Biotech Pulse: Sarepta Gene Therapy Study Readout, Novavax Vaccine Supply Deal, 2 IPOs
    benzinga.com

    The Daily Biotech Pulse: Sarepta Gene Therapy Study Readout, Novavax Vaccine Supply Deal, 2 IPOs

    Here's a roundup of top developments in the biotech space over the last 24 hours.
    Scaling The Peaks
    (Biotech Stocks Hitting 52-week Highs Jan. 7) …

Schreibe einen Kommentar

Wenn du schon einen Account hast, logge dich ein bevor du den Kommentar absendest.

Galue Account Vorteile
  • Battles

    Messe dich mit der Community in Battles.

  • Badges

    Erhalte Belohnungen für Kommentare, die der Community helfen.

  • Mehr Informationen für alle

    Poste Bilder oder Videos zu Themen und Unternehmen und helf dabei, dass Investoren ein kontroverseres Bild erhalten.

  • Kein Datenrisiko

    Du kannst jederzeit deinen Account löschen und gespeicherte Daten einsehen.

ETFs die in MiMedx Group, Inc investieren

Dir gefallen die Informationen zu MiMedx?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:

Zu BUX Zero

Dir gefallen die Informationen zu MiMedx?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:

Zur Comdirect

Dir gefallen die Informationen zu MiMedx?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:

Zu Trade Republic

Dir gefallen die Informationen zu MiMedx?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:

Zur ING Diba